The approval was based on data from 2 prospective, randomized, double-blind placebo-controlled clinical studies.
这次批准的依据是2次前瞻性随机双盲安慰剂控制对照临床研究的数据。
The answer is the "gold standard" double blind, placebo controlled study.
答案是“金标准”,双盲,安慰剂对照研究。
So, in fact, this double blind placebo controlled study does not guarantee safety or efficacy because the test leaves far too many questions unanswered.
所以实际上,双盲对照研究并不会保证疗效和安全,因为它留下太多无法回答的问题。
应用推荐